Celecoxib Capsules 200 mg recalled for foreign tablets inside bottles
Alembic Pharmaceuticals is recalling Celecoxib 200 mg capsules after a customer found a Tadalafil 5 mg tablet inside a sealed 500-count bottle. The contamination was discovered through a customer complaint.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: FDA Class II recall involving a foreign object (unapproved medication) in a sealed prescription drug container presents a significant contamination issue that could result in unintended drug ingestion and potential patient harm, meeting the criteria for Severe classification.
Plain-English summary
Alembic Pharmaceuticals Limited is recalling Celecoxib Capsules, 200 mg, because a customer complaint identified a Tadalafil 5 mg tablet inside a sealed 500-count bottle. The affected product is batch 2405014780 with an expiration date of September 30, 2027, distributed nationwide and in Puerto Rico.
The presence of a foreign tablet in a sealed container presents a safety risk. Consumers who have this product and suspect they may have received contaminated bottles should stop using it and contact their pharmacy or healthcare provider.
Patients taking this medication should not stop treatment without consulting their healthcare provider. If you have the recalled batch number, contact Alembic Pharmaceuticals or your pharmacy for instructions on how to proceed.
The recalled product
- Product
- Celecoxib Capsules, 200 mg, 500-count bottle, Rx only, Manufactured by: Alembic Pharmaceuticals Limited (Formulation Division), Panelav 389350, Gujarat, India, Manufactured for: Alembic Pharmaceuticals, Inc., Bedminster, NJ 07921, USA, NDC 62332-142-71
- Manufacturer
- Alembic Pharmaceuticals Limited
- Category
- Drug — Prescription / NSAID
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Batch 2405014780
- Exp. Date: Sep. 30
- 2027
Distribution
Related recalls
Same manufacturer · Alembic Pharmaceuticals Limited
See all →- ModerateFesoterodine extended-release tablets recalled over a diester impurity above specification
FDA (Drugs) · 2026-01-14
- ModerateFesoterodine tablets recalled after a diester impurity exceeded its specification limit
FDA (Drugs) · 2025-11-26
- HighDoxepin hydrochloride capsules exceed the interim nitrosamine impurity limit
FDA (Drugs) · 2025-08-13
- ModerateBromfenac Ophthalmic Solution 0.09% Recalled for Failed Impurities Specifications
FDA (Drugs) · 2025-06-04
- SevereAlembic Pharmaceuticals Recalls Telmisartan Tablets Due to Labeling Error
FDA (Drugs) · 2021-04-14
Same hazard · foreign object
See all →- SevereOutshine Black Cherry Fruit Bars Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02
- SevereOutshine Fruit Bars Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02
- SevereOutshine Watermelon Fruit Bars Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02
- SevereOutshine Strawberry Fruit Bars Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02
- SevereOutshine Fruit Bars Grape Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02